▸case-01 We are preparing to launch a multi-channel patient marketing campaign for our new medical device. Can you map out a structured regulatory review process and setup guide, including what pre-checks to run, how to assign reviewer SLAs, key elements to check across our ad copy and landing pages, and how to maintain an audit trail for compliance? | fail→pass | 20,967 | 20,022 | -5% | 1 | 1 | 0% | 3,124 | 3,725 | +19% | 0 | 0 | — |
▸case-02 Our team needs to conduct a compliance audit on our current digital healthcare ads and landing pages before our quarterly review. Please build a comprehensive regulatory inspection checklist and decision tracking framework that covers reviewer roles, asset verification steps, and post-launch trigger tracking. | fail→fail | 25,310 | 20,827 | -18% | 1 | 1 | 0% | 4,135 | 3,333 | -19% | 0 | 0 | — |
▸case-03 We are designing a Phase II clinical study for a novel oncology asset and need a protocol outline covering patient safety monitoring, inclusion/exclusion criteria, and IRB submission requirements. Please outline the IRB protocol document structure. | pass→pass | 21,305 | 25,243 | +18% | 1 | 1 | 0% | 3,651 | 4,454 | +22% | 0 | 0 | — |
▸case-04 Our infrastructure team is configuring AES-256 database encryption at rest and TLS 1.3 in transit for a cloud electronic health record (EHR) repository under HIPAA Security Rule requirements. What technical safeguard documentation should we generate? | pass→pass | 18,843 | 15,806 | -16% | 1 | 1 | 0% | 3,049 | 2,762 | -9% | 0 | 0 | — |
▸case-05 We are preparing an FDA 510(k) premarket notification dossier for a Class II diagnostic ultrasound device. What engineering testing summaries and substantial equivalence documentation must be compiled for FDA submission? | pass→pass | 24,869 | 24,468 | -2% | 1 | 1 | 0% | 3,989 | 4,118 | +3% | 0 | 0 | — |
▸case-06 We are launching a promotional campaign for a prescription diabetes drug and team members often submit unapproved claim drafts without references. To streamline intake, what specific pre-check verification steps should be mandatory before any reviewer evaluates the submission? | pass→pass | 16,654 | 17,793 | +7% | 1 | 1 | 0% | 2,252 | 2,807 | +25% | 0 | 0 | — |
▸case-07 A junior marketing manager proposed routing our new telehealth landing page review to only Legal and Medical to save time. What full set of functional reviewer roles must be mapped into the review routing matrix to ensure complete healthcare regulatory coverage? | pass→pass | 19,535 | 16,665 | -15% | 1 | 1 | 0% | 2,784 | 2,599 | -7% | 0 | 0 | — |
▸case-08 When building an asset compliance review spreadsheet for a new digital patient portal recruitment page, our team usually only inspects written copy and visual creative. What additional digital tracking and data routing elements must be verified on the asset checklist? | pass→pass | 17,327 | 16,825 | -3% | 1 | 1 | 0% | 2,426 | 2,655 | +9% | 0 | 0 | — |
▸case-09 We are expanding our consumer health ad campaign across Spanish-speaking and French-Canadian markets. In addition to core copy and creative, what key asset checklist item must be included to catch regional translation or regulatory nuances? | pass→pass | 13,721 | 12,047 | -12% | 1 | 1 | 0% | 1,833 | 1,865 | +2% | 0 | 0 | — |
▸case-10 During an internal regulatory audit, inspectors flagged that several active campaign disclaimers used outdated clinical trial citations. How should decision logging be structured to prevent expired clinical evidence from being used in active assets? | pass→pass | 18,313 | 15,920 | -13% | 1 | 1 | 0% | 2,650 | 2,526 | -5% | 0 | 0 | — |
▸case-11 When recording regulatory approval outcomes for high-risk medical device claims, what critical audit trail component must be attached directly to each approval record so regulators can inspect the supporting documentation? | fail→pass | 11,462 | 8,536 | -26% | 1 | 1 | 0% | 1,512 | 1,552 | +3% | 0 | 0 | — |
▸case-12 A marketing team member noticed a social media comment on a drug campaign ad where a patient describes experiencing severe nausea after taking the drug. What post-launch compliance monitoring procedure must be triggered immediately? | pass→pass | 8,084 | 8,913 | +10% | 1 | 1 | 0% | 1,160 | 1,518 | +31% | 0 | 0 | — |
▸case-13 After launching a digital health campaign, the clinical team published an updated clinical study that modifies the primary endpoint results cited in our ad claims. What post-launch mechanism ensures these assets are pulled or revised? | pass→pass | 13,206 | 9,034 | -32% | 1 | 1 | 0% | 1,991 | 1,499 | -25% | 0 | 0 | — |
▸case-14 Our regulatory review board is overwhelmed with individual, piece-meal submissions for every social banner, email header, and landing page. How should marketing assets be structured during intake to streamline review SLA performance? | pass→pass | 16,515 | 12,502 | -24% | 1 | 1 | 0% | 2,365 | 2,277 | -4% | 0 | 0 | — |
▸case-15 Our agency suggested omitting claim reference checks during intake for short-form social media ads to meet a tight launch deadline. How should the promotional review intake process handle claim reference verification prior to routing? | pass→pass | 17,055 | 15,818 | -7% | 1 | 1 | 0% | 2,341 | 2,440 | +4% | 0 | 0 | — |
▸case-16 Our medical review team frequently takes over three weeks to review ad copy because no clear turnaround expectations were set. How should SLAs be integrated into the regulatory routing sheet? | fail→fail | 16,057 | 13,673 | -15% | 1 | 1 | 0% | 2,430 | 2,383 | -2% | 0 | 0 | — |
▸case-22 Why is it necessary to establish concrete expiration dates for regulatory approvals on pharmaceutical promotional claims, and what triggers those expiration dates? | pass→pass | 14,531 | 14,243 | -2% | 1 | 1 | 0% | 2,035 | 2,288 | +12% | 0 | 0 | — |
▸case-17 A legal reviewer approves a patient brochure only on the condition that font size for the safety disclaimer is increased to 10pt. Where and how should conditional approvals be documented for audit compliance? | fail→pass | 13,586 | 11,720 | -14% | 1 | 1 | 0% | 1,985 | 1,960 | -1% | 0 | 0 | — |
▸case-18 We are standardizing our compliance review asset toolkit. What specific fields must be included in the review routing sheet template to maintain reviewer accountability? | fail→pass | 14,384 | 14,714 | +2% | 1 | 1 | 0% | 2,074 | 2,488 | +20% | 0 | 0 | — |
▸case-19 We need to create a standardized spreadsheet for our creative agency partners to complete before submitting materials for medical review. What key media touchpoints and technical asset components must the asset checklist spreadsheet cover? | fail→pass | 21,036 | 16,340 | -22% | 1 | 1 | 0% | 2,845 | 2,649 | -7% | 0 | 0 | — |
▸case-20 To prepare for potential FDA or FTC promotional compliance audits, what specific decision logging template must be maintained to document every asset clearance? | pass→pass | 16,686 | 16,156 | -3% | 1 | 1 | 0% | 2,270 | 2,644 | +16% | 0 | 0 | — |
▸case-21 A web developer modified a patient sign-up form on a live healthcare campaign site to add a new demographic field without regulatory sign-off. What post-launch protocol was breached and should be enforced to prevent unauthorized live edits? | pass→pass | 8,559 | 11,563 | +35% | 1 | 1 | 0% | 1,295 | 1,889 | +46% | 0 | 0 | — |